19 February 2026

Biologics Clinical research Psoriasis

GLP-1/biologics combo delivers double win in PsA

5 February 2026

Obesity Public Health

Stopping weight-loss drugs triggers rapid rebound

27 November 2025

Obesity Pharmaceuticals Surgery

GLP-1s could help avoid follow-up bariatric surgery

2 October 2025

Clinical research Obesity

BMJ retracts vinegar weight loss trial

2 October 2025

Clinical research Obesity Rheumatoid Arthritis

GLP-1 drugs could do double duty in RA

26 June 2025

Diabetes Obesity Pharmaceuticals

Oral GLP-1RA could ‘revolutionise’ obesity management: expert

15 May 2025

Diabetes Obesity Pharmaceuticals

Obesity drug leads to 25% weight loss in a third of patients

18 December 2024

Obesity Public Health Smoking

Smoking overtaken as No 1 contributor to disease burden

18 December 2024

Diabetes Obesity

Even more things GLP-1 RAs can do

21 November 2024

Diabetes Obesity

Tirzepatide safe, highly effective for three years

26 September 2024

Obesity Paediatrics

Obese kids risk eczema, psoriasis, alopecia

29 August 2024

Diabetes Obesity

‘Exciting’ discovery on metabolic disease triggers

29 August 2024

Obesity Pharmaceuticals Surgery

Bariatric surgery declining amid rise of GLP-1 RAs

18 July 2024

Diabetes Obesity

Tirzepatide beats semaglutide for weight loss

4 July 2024

Diabetes Obesity Political TGA

First generic GLP-1 RAs in the approval pipeline

6 June 2024

Diabetes PBS Political

PBS rejigs rules on GLP-1s and other diabetes meds